PTK2B and neoplasm: Immunohistochemistry (IHC) is the most frequently applied method for evaluating PTK expression in tumor tissues, however, it requires tissue biopsies, which are not always available and furthermore, do not always represent the pathology of the whole tumor nor of distant, unexamined metastases.